Publikationen von F. Ohl

Erhardt, A.; Welt, T.; Rödel, A.; Habersetzer, U.; Stecker, G.; Ohl, F.; Keck, M. E.: Consequences of chronic social stress on behavior, HPA-system regulation and AVP gene expression in the PVN, amygdala and hippocampus in mice - influence of CRH1-receptor antagonism. Pharmacopsychiatry 36 (5), S. 223 - 223 (2003)

Ohl, F.; Binder, E. B.; Rödel, A.; Weissenbacher, P.; Keck, M. E.: ENU-mouse mutagenesis screen: In search of animal models of psychiatric disorders. Pharmacopsychiatry 36 (5), S. 252 - 252 (2003)

Räder, H.; Grunze, H.; Ohl, F.; Keck, M. E.; Giegling, I.; Rujescu, D.: Effects of chronic MK-801 treatment on the relative mRNA expression of NMDA receptor subunits and splice variants in a pharmacological model for psychosis. Pharmacopsychiatry 36 (5), S. 254 - 254 (2003)

Rödel, A.; Storch, C.; Ohl, F.: Influence of circadian factors on behavioral and cognitive testing in mice. Pharmacopsychiatry 36 (5), S. 256 - 256 (2003)

Sillaber, I.; Ohl, F.; Bartl, C.; Panhuysen, M.; Henniger, M. S. H.; Holsboer, F.: Inbred mouse strains as models for the detection of genes relevant for the effects of antidepressants. Pharmacopsychiatry 36 (5), S. 265 - 265 (2003)

Weissenbacher, P.; Ohl, F.: Refinement of inbred mouse strains as animal models for psychiatric disorders. Pharmacopsychiatry 36 (5), S. 272 - 272 (2003)

Keck, M. E.; Welt, T.; Müller, M. B.; Uhr, M.; Ohl, F.; Wigger, A.; Toschi, N.; Holsboer, F.; Landgraf, R.: Reduction of hypothalamic vasopressinergic hyperdrive contributes to clinically relevate behavioral and neuroendocrine effects of chronic paroxetine treatment in a psychopathological rat model. Neuropsychopharmacology 28 (2), S. 235 - 243 (2003)

Schmidt, M.; Oitzl, M. S.; Müller, M. B.; Ohl, F.; Wurst, W.; Holsboer, F.; Levine, S.; De Kloet, E. R.: Regulation of the developing hypothalamic-pituitary-adrenal axis in corticotropin releasing hormone receptor 1-deficient mice. Neuroscience 119 (2), S. 589 - 595 (2003)

Rujescu, D.; Bender, A.; Keck, M.; Ohl, F.; Rader, H.; Grunze, H.: A pharmacological model for psychosis. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 114 (7), S. 869 - 869 (2002)

Neumann, I. D.; Toschi, N.; Ohl, F.; Torner, L.; Krömer, S. A.: Maternal defence as an emotional stressor in female rats: Correlation of neuroendocrine and behavioural parameters and involvement of brain oxytocin. European Journal of Neuroscience 13, S. 1016 - 1024 (2001)

Ohl, F.; Holsboer, F.; Landgraf, R.: The modified hole boards as a differential screen for behavior in rodents. Behavior Research Methods, Instruments, & Computers 33, S. 392 - 397 (2001)

Ohl, F.; Sillaber, I.; Binder, E.; Keck, M. E.; Holsboer, F.: Differential analysis of behavior and diazepam-induced alterations in C 57 BL/6 N and BALB/c mice using the modified hole board test. Journal of Psychiatric Research 35, S. 147 - 154 (2001)

Ohl, F.; Toschi, N.; Wigger, A.; Henniger, M. S. H.; Landgraf, R.: Dimensions of emotionality in a rat model of innate anxiety. Behavioral Neuroscience 115, S. 429 - 436 (2001)

Henniger, M. S. H.; Ohl, F.; Hölter, S. M.; Weißenbacher, P.; Toschi, N.; Lörscher, P.; Wigger, A.; Spanagel, R.; Landgraf, R.: Unconditioned anxiety and social behaviour in two rat lines selectively bred for high and low anxiety-related behaviour. Behavioural Brain Research 111, S. 153 - 163 (2000)

Kimura, M.; Ohl, F.: Schlaf-EEG bei Mäusen und Ratten. In: Handbuch der psychiatrischen Pharmakotherapie. 2., vollst. überarb. u. akt. Aufl., S. 129 - 132 (Hg. Gründer, G.; Benkert, O.). Springer, Berlin (2012)